RxDoctor Payments DataLook up a doctor →

Mirela Cerghet

Neurology · Detroit, MINPI 1427171677

Payments from drug & device makers

$3,776,709in general payments, 2019–2025

Across 250 payments — averaging $15,107 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2.6M
  • Genentech, Inc.$689K
  • Sanofi$78K
  • Biogen$78K
  • Roche Products Limited$72K
  • F. Hoffmann-la Roche AG$72K
  • plus $163K from 7 others
$2,913in research payments, 2019–2025

Across 19 payments — averaging $153.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$2K
  • EMD Serono, Inc.$604

General payments by program year

22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,776,709 in reported general payments places this provider in the 95th percentile of 652 neurology providers in Michigan.

See all neurology providers in Michigan

Medicare billing

Part B allowed, 2024
$27,792
Medicare patients
171
Services billed
324

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →